New Avenues for Pharmacological Management of Hyperphagia and Associated Behavioral Disorders in Prader-Willi Syndrome
- PMID: 36896885
- DOI: 10.1210/clinem/dgad131
New Avenues for Pharmacological Management of Hyperphagia and Associated Behavioral Disorders in Prader-Willi Syndrome
Keywords: Prader-Willi syndrome (PWS); behavioral alterations; hyperphagia; obesity; oxytocin; treatment.
Comment on
-
Intranasal Carbetocin Reduces Hyperphagia, Anxiousness, and Distress in Prader-Willi Syndrome: CARE-PWS Phase 3 Trial.J Clin Endocrinol Metab. 2023 Jun 16;108(7):1696-1708. doi: 10.1210/clinem/dgad015. J Clin Endocrinol Metab. 2023. PMID: 36633570 Free PMC article. Clinical Trial.
-
Diazoxide Choline Extended-Release Tablet in People With Prader-Willi Syndrome: A Double-Blind, Placebo-Controlled Trial.J Clin Endocrinol Metab. 2023 Jun 16;108(7):1676-1685. doi: 10.1210/clinem/dgad014. J Clin Endocrinol Metab. 2023. PMID: 36639249 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical